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Structural insights into the function of ZRANB3
in replication stress response
Marek Sebesta1, Christopher D.O. Cooper1,w, Antonio Ariza1, Christopher J. Carnie1 & Dragana Ahel1
Strategies to resolve replication blocks are critical for the maintenance of genome stability.
Among the factors implicated in the replication stress response is the ATP-dependent
endonuclease ZRANB3. Here, we present the structure of the ZRANB3 HNH (His-Asn-His)
endonuclease domain and provide a detailed analysis of its activity. We further deﬁne PCNA
as a key regulator of ZRANB3 function, which recruits ZRANB3 to stalled replication forks and
stimulates its endonuclease activity. Finally, we present the co-crystal structures of PCNA
with two speciﬁc motifs in ZRANB3: the PIP box and the APIM motif. Our data provide
important structural insights into the PCNA-APIM interaction, and reveal unexpected
similarities between the PIP box and the APIM motif. We propose that PCNA and
ATP-dependency serve as a multi-layered regulatory mechanism that modulates ZRANB3
activity at replication forks. Importantly, our ﬁndings allow us to interpret the functional
signiﬁcance of cancer associated ZRANB3 mutations.
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D
NA replication is a fundamental process critical for cell
survival. To achieve successful transmission of genetic
information, cells must ensure precise and timely
duplication of their genomic content. This is compounded by
the fact that speciﬁc conditions impose ‘replication stress’ and
interfere with the replication process. Fortunately, cells have
evolved mechanisms capable of dealing with a wide range of
genotoxic insults.
Cellular responses to replication-associated DNA damage are
centred around Proliferating Cell Nuclear Antigen (PCNA), a
DNA clamp that acts as a processivity factor for eukaryotic DNA
polymerases1. The roles of PCNA in normal DNA replication and
in the replication stress response are supported by its ability to act
as a molecular platform for the recruitment of speciﬁc protein
factors. The interactions of PCNA with its protein partners are
mediated through speciﬁc PCNA interaction peptides, which
generally belong to one of two types. One is the PCNA-
Interacting Protein (PIP) box, a short sequence deﬁned by Q-x-x-
[VILM]-x-x-[FY]-[FY] consensus2, and the other is the AlkB
homologue 2 PCNA Interacting Motif (APIM), characterized by
the sequence [KR]-[FYW]-[LIVA]-[LIVA]-[KR]3. Available co-
crystal structures reveal that PIP box peptides interact with the
hydrophobic pocket on the PCNA surface, buried under the long
stretch of residues known as the interdomain connecting loop
(IDCL)1. However, in contrast to the multitude of structures
available for different PCNA:PIP box complexes, an atomic
resolution structure of PCNA:APIM complex is currently
missing.
Among the proteins that interact with PCNA are
structure-speciﬁc nucleases associated with DNA replication
and DNA repair, such as Zinc-ﬁnger, RAN-Binding domain
containing 3 (ZRANB3) and Flap Endonuclease 1 (FEN1). In
general, structure-speciﬁc nucleases process secondary DNA
structures that arise as intermediates during DNA replication,
DNA repair and recombination. FEN1 processes the 50-ﬂap
structures in DNA replication and DNA repair4. Roles of FEN1 in
numerous DNA metabolic pathways have been studied intensely
over the years and our insight into its function is supported by the
available structural data5–8. In contrast to this, ZRANB3 is
relatively underexplored and its biological roles are not well
understood.
Previous studies have shown that ZRANB3 localizes to the sites
of ongoing DNA replication, and interacts with PCNA and
subunits of the replicative helicase complex MCM9. Furthermore,
it is recruited to DNA breaks and stressed replication forks, and
its deﬁciency leads to an increased sensitivity to certain DNA
damaging agents9–11. Structurally, ZRANB3 belongs to the
Sucrose Non-Fermenting 2 (SNF2) family of ATPases and
contains several identiﬁable domains and motifs, which provide
speciﬁcity for a number of deﬁned substrates. These include the
amino-terminal SNF2 ATPase core, two PCNA binding motifs
(the PIP box and the APIM motif), a speciﬁc type of zinc-ﬁnger
(Npl4 Zinc-Finger, NZF) and the HNH nuclease domain (named
after the three most conserved residues) (Fig. 4b).
Unlike FEN1, ZRANB3 is a highly unusual endonuclease and
cleaves its DNA substrate in an ATP-dependent manner9. The
nuclease activity is supported by the carboxy-terminal HNH
domain, which is also found in a variety of bacterial and viral
proteins (including homing endonucleases, bacterial toxins,
restriction endonucleases, transposases and DNA packaging
factors12,13). Bacterial HNH domains are known to act as both
site-speciﬁc DNA nucleases (in homing nucleases for example, or
in the RNA-guided DNA endonuclease Cas9), as well as
non-speciﬁc nucleases (in colicins, a subgroup of bacterial
toxins)14,15. Interestingly, in eukaryotic ZRANB3 protein the
HNH domain supports the structure-speciﬁc endonuclease
activity9, which might be associated with the role of ZRANB3
in the replication stress response. However, it remains unclear
how this is achieved on a molecular basis.
Here, we present a detailed analysis of ZRANB3 activity and
provide structural insights into its endonuclease function. We
also explore the relevance of the ZRANB3:PCNA interaction and
consider the biological implications of this association. Our data
highlight multiple roles of PCNA, both as a molecular scaffold for
the recruitment of replication-associated protein complexes, as
well as a speciﬁc modulator of enzymatic activities. We show that
PCNA not only plays a critical role in targeting ZRANB3 to the
sites of DNA replication, but that it also serves as a cofactor and
stimulates ATP-dependent ZRANB3 endonuclease activity.
Furthermore, we provide structural evidence of the PCNA:APIM
complex and demonstrate that, despite the differences in
amino-acid sequence, the PIP box and the APIM motif share
similar topology and bind to the same molecular surface of the
PCNA ring. Finally, our structural and biochemical analyses
enable us to assess the functional relevance of cancer associated
mutations of ZRANB3. We demonstrate a high incidence of
impaired and/or loss-of-function mutations that likely contribute
to genomic instability in this context.
Results
Structure of the ZRANB3 HNH domain. To gain structural
insight into the ZRANB3 HNH domain, we solved the crystal
structure of the C-terminal region of the ZRANB3 (residues
948-1067) by experimental phasing. The HNH structure contains
two HNH molecules in the asymmetric unit that are structurally
similar, with an RMSD of 0.76Å over 117 equivalent Ca atoms.
Each HNH molecule contains one two-stranded anti-parallel b-
sheet (b1–b2) surrounded by eight helices (a1–a8). The structure
adopts a bba fold16, typically found in the HNH protein family. It
also contains a non-catalytic zinc-ﬁnger coordinated with four
cysteine residues (Fig. 1a and Supplementary Fig. 1), conserved in
a subset of HNH proteins containing the C-x-x-C dyad14. A
structural homology search using the DALI server17 identiﬁed the
closest structural homologues of the ZRANB3 HNH domain as
phage T4 endonuclease VII, a Holliday junction-speciﬁc resolvase
(PDB code 1EN7; ref. 18), and the HNH nicking endonuclease
from Geobacter metallireducens (PDB code 4H9D; ref. 19)
(Fig. 1b). Interestingly, sequence comparisons with other zinc-
ﬁnger containing HNH proteins revealed the presence of the
HNH insert (Fig. 1c), speciﬁc to ZRANB3 and the self-standing
HNH proteins found in Acidobacterium bacterium and Solibacter
usitatus, but absent from other HNH proteins. Overlays of the
ZRANB3 HNH structure with its closest structural homologues
showed that this ZRANB3-speciﬁc HNH insert adopts a
well-structured a-helical domain (Fig. 1a,d). Deletion of this
domain led to the loss of ZRANB3 endonuclease activity (and a
reduction, but not a complete loss of the ATPase activity, Fig. 1e
and Supplementary Fig. 2a; Table 2), raising a possibility that it
might be important for the structure-speciﬁc recognition of the
DNA substrate.
DNA binding surface. Analysis of the electrostatic surface
potential of the HNH domain revealed a predominantly
electropositive face (Fig. 2a), with a continuous positively charged
region encompassing helices a1 and a8, as well as helices a2 and
a3 in the ZRANB3-speciﬁc helical domain (Fig. 2b). Overlay of
the HNH and T4 endonuclease VII structures showed that helix
H2 in T4 endonuclease VII, which penetrates into the Holliday
junction and stabilizes the separation between exchanging
DNA strands, overlaps with the helix a8 in the HNH structure
(Fig. 2c), suggesting a potential involvement of helix a8 in DNA
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binding. To address the role of the positively charged regions of
the HNH domain, we introduced a number of mutations
targeting the ZRANB3-speciﬁc helical region and helix a8
(Fig. 1c). Some of these mutations resulted in reduced DNA
binding by the HNH domain (Supplementary Fig. 3b), and had a
pronounced effect on the ZRANB3 endonuclease activity- as
observed with the K1046A, R1048A double mutant in helix a8,
and with the R1009A mutant in the ZRANB3-speciﬁc helical
domain (Fig. 2d,e). Interestingly, the K1046A, R1048A double
mutant retained efﬁcient ATPase activity (Fig. 2e, Table 2), sug-
gesting that the impact of the mutations on the endonuclease
function was not linked to the ability to hydrolyse ATP. The
DNA binding surface therefore likely involves helix a8 and
certain positively charged regions within the ZRANB3-speciﬁc
helical domain.
Characterization of the active site. Analysis of the electrostatic
surface potential also revealed the presence of a negatively
charged patch on a predominantly electropositive face of the
HNH molecule (Figs 2a and 3a). Interestingly, overlay of the
HNH and T4 endonuclease VII structures showed that the
observed electronegative patch in HNH overlaps with the Mg2þ
ion binding pocket in the T4 endonuclease VII active site
(Fig. 3a). To gain insight into the architecture of the HNH cat-
alytic site, we further analysed the structure of the ZRANB3 HNH
domain superimposed to that of the inactive T4 endonuclease VII
(N62D) in complex with the Holliday junction DNA substrate.
The active site of T4 endonuclease VII adopts a characteristic
bba-metal fold, and contains a Mg2þ ion and catalytically
essential residues Asp40, His41 and Asn62 (refs 20–22) (Fig. 3b).
The Mg2þ ion is coordinated by the side chains of Asp40 and
Asn62Asp, two oxygen atoms of the scissile phosphate and a
water molecule22. A catalytic mechanism involves His41, which
likely acts as a general base and activates water for nucleophilic
attack. On the other hand, the Mg2þ ion is thought to stabilize
the phosphoanion transition state and facilitate product
formation. Although the structure of the ZRANB3 HNH
domain does not reveal the presence of a divalent cation in the
putative active site, residues Asp1020, His1021 and His1045
assume equivalent positions to the catalytically important
residues within the bba-metal fold of T4 endonuclease VII
(Fig. 3b). Sequence comparisons show strict conservation of
Asp1020 and His1021 and His1045 among ZRANB3 proteins,
highlighting their importance (Fig. 1c). By analogy with the T4
endonuclease VII structure, we hypothesized the involvement of
Asp1020 and His1045 in metal coordination, and the role of
His1021 as a general base in nucleophilic attack.
To address the relevance of speciﬁc residues in the bba-fold of
HNH domain, we introduced a number of mutations and tested
the activities of the mutant ZRANB3 proteins. Although the
mutations did not have a dramatic effect on DNA-dependent
ATP hydrolysis (Supplementary Fig. 2c, Table 2), some of them
either substantially reduced (N1036A), or completely abrogated
(D1020A, H1021A and H1045A) ZRANB3 endonuclease activity
(Fig. 3c). This is consistent with the proposed catalytic roles of
Asp1020, His1021 and His1045 in the nucleolytic cleavage of
DNA substrate.
ZRANB3 differs from other characterized HNH nucleases in
being an ATP-dependent nuclease. Our previous work showed
that mutation of the conserved Lys65 in the ATP-binding motif
of ZRANB3 (known as the Walker A motif) yielded an ATPase-
deﬁcient enzyme9. Although the ATPase dead ZRANB3 mutant
K65R showed no detectable endonuclease activity, it was unclear
whether this was due to its inability to hydrolyse ATP, or due to
the possible effect of the K65R mutation on the binding of ATP.
To test whether ATP hydrolysis is essential for endonuclease
activity, we tested ZRANB3 endonuclease activity in the presence
of non-hydrolysable ATP analogues (ATPgS, AMP-PNP,
AMP-PCP). Our data show that substitution of ATP by
non-hydrolysable ATP analogues in ZRANB3 endonuclease
reactions resulted in a complete loss of activity (Fig. 3d).
ZRANB3 endonuclease activity is therefore strictly dependent
on ATP hydrolysis catalysed by the helicase core domain.
Stimulation of nuclease activity by PCNA. Given that ZRANB3
acts as a structure-speciﬁc endonuclease, we compared its activity
to an archetypal structure-speciﬁc endonuclease: FEN1. FEN1 is
known to interact with PCNA through the PIP box located at its
C-terminus5,6, and this association was shown to stimulate
endonuclease activity of FEN1 (refs 23,24). We therefore sought
to test whether PCNA also has an effect on the endonuclease
activity of ZRANB3. Our results show that, similarly to FEN1
activation, increasing concentrations of PCNA stimulated
endonuclease activity of ZRANB3 (Fig. 4a). To gain molecular
insight into this activation, we decided to explore the way
ZRANB3 interacts with PCNA. Previous studies identiﬁed two
conserved PCNA binding motifs in ZRANB3: a PIP box located
between residues 519 and 526, and an APIM motif located at the
very C-terminal end of the ZRANB3 protein (Fig. 4b, ref. 10). We
inactivated the PIP box and the APIM motif by mutating critical
residues (Fig. 4b,c), and assessed the impact of PCNA interactions
on ZRANB3 endonuclease activity. Whereas the wild-type
ZRANB3 showed notable stimulation of endonuclease activity
in the presence of PCNA, such stimulation could not be observed
upon inactivation of either the PIP box or the APIM motif
(mutants PIP* and DAPIM, respectively) (Fig. 4d,e). An additive
effect could not be observed with the PIP*-DAPIM double
mutant, which highlights the relevance of both PCNA binding
motifs for optimal ZRANB3 endonucleolytic activity.
Interestingly, PCNA did not stimulate the ATPase activity of
ZRANB3 (Supplementary Fig. 2d). Moreover, mutations of the
PCNA binding motifs did not affect ATPase function
(Supplementary Fig. 2e, Table 2), suggesting that ZRANB3
employs distinct mechanisms for activation (by ATP hydrolysis)
and stimulation (by PCNA binding) of its endonuclease activity.
PCNA-dependent recruitment of ZRANB3. We next wanted to
address the importance of PCNA in targeting structure-speciﬁc
nucleases to sites of DNA damage. We expressed YFP-tagged
proteins in U2OS cells and examined their ability to localize at
sites of DNA damage caused by Ultraviolet laser microirradiation.
As shown in Fig. 5a, YFP-FEN1 was efﬁciently recruited to the
sites of laser-induced DNA damage. However, mutation of the
PIP box motif resulted in a dramatic loss of FEN1 recruitment to
the microirradiated stripes (YFP-FEN1 PIP* mutant),
highlighting the importance of PCNA in mobilizing FEN1 to the
appropriate nuclear locations. We further examined the
recruitment of ZRANB3 to DNA damage, which was previously
suggested to employ a similar PCNA-dependent mechanism9,10.
To address the relevance of the individual PCNA binding motifs
in ZRANB3 more directly, we expressed them as YFP-tagged
proteins with nuclear localization signals. As shown in Fig. 5b,
both the PIP box and the APIM motif were efﬁciently mobilized
to the sites of DNA damage. However, this was completely
abrogated when mutations, shown to abolish interactions with
PCNA (Fig. 4c), were introduced into the PIP box and the APIM
motif (Fig. 5b, mutants PIP*and APIM*). To address the
relevance of these motifs in the context of the full length
ZRANB3 protein, we further tested the recruitment of
YFP-ZRANB3 wild-type and mutant proteins to locally induced
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DNA damage. In agreement with the published data10, ZRANB3
was readily recruited to the microirradiated stripes, and the
individual inactivation of either the PIP box or the APIM motif
(mutants PIP* and DAPIM, respectively) was not sufﬁcient to
abrogate recruitment to DNA damage (Fig. 5c). The recruitment
of ZRANB3 was abolished only upon inactivation of both PCNA
binding motifs (PIP*-DAPIM double mutant, Fig. 5c), indicating
that the PIP box and the APIM motif might act independently in
a biological context to support PCNA-dependent recruitment to
DNA damage.
We also examined the relevance of PCNA binding motifs in
targeting ZRANB3 to the sites of DNA replication. To do this, we
expressed YFP-ZRANB3 wild-type and mutant proteins and
analysed their ability to colocalize with endogenous PCNA. In
undamaged conditions, the majority of YFP-ZRANB3 expressing
cells show uniform nuclear expression (such as in Fig. 5c).
However, about 20% of the cells expressing YFP-ZRANB3 form
foci, which colocalize with PCNA (Fig. 5d,e and Supplementary
Fig. 4) (ref. 9). Individual mutation of either of the PCNA binding
motifs in ZRANB3 reduced the efﬁciency of foci formation (PIP*
and DAPIM mutants, Fig. 5e), but a complete loss of
colocalization with PCNA was observed only upon inactivation
of both motifs (PIP*-DAPIM double mutant, Fig. 5d,e). This
indicates that the PIP box and the APIM motif mediated
interactions with PCNA play critical roles in the recruitment of
ZRANB3 to the sites of ongoing DNA replication.
ZRANB3 is also known to play a role in the replication
stress response and to accumulate at sites of stalled DNA
replication9–11. To address the signiﬁcance of PCNA-binding
motifs in recruiting ZRANB3 to stalled replication forks, we
Table 1 | Summary of crystallographic statistics.
HNH-Pt HNH PCNA:PIP PCNA:APIM
Data collection
Wavelength (Å)/beam line 1.0721/I03 0.9174/I04-1 1.1402/I04 1.2822/I03
Detector Pilatus3 6M Pilatus 2M Pilatus 6M-F Pilatus3 6M
Space group P21 21 21 P21 21 21 P21 21 21 P31 21
a (Å) 54.14 56.84 68.14 84.63
b (Å) 61.14 67.55 86.80 84.63
c (Å) 75.34 92.16 156.69 201.80
a () 90.00 90.00 90.00 90.00
b () 90.00 90.00 90.00 90.00
g () 90.00 90.00 90.00 120.00
Content of asymmetric unit 2 2 3 3
Resolution (Å) 27.59–2.39 (2.45–2.39) 54.48–2.00 (2.05–2.00) 78.34–1.96 (2.01–1.96) 73.29–2.45 (2.55–2.45)
Rsym (%)* 6.6 (65.0) 20.8 (186.2) 8.4 (176.3) 10.4 (129.7)
I/s (I) 15.4 (2.9) 11.0 (1.4) 20.2 (1.5) 15.1 (2.0)
Completeness (%) 99.7 (99.3) 99.9 (99.7) 100.0 (100.0) 100.0 (100.0)
Redundancy 6.4 (6.6) 13.2 (11.9) 13.0 (13.1) 11.2 (9.7)
CC1/2 (%) (81.5) (52.2) (56.6) (56.5)
Number of unique reﬂections 10,367 (748) 24,666 (1,783) 67,566 (4,503) 31,686 (3,528)
Reﬁnement
Rcryst (%)
w 25.7 19.2 21.1 22.1
Rfree (%)
z 30.5 23.6 25.9 26.4
Rmsd bond length (Å) 0.017 0.013 0.010 0.011
Rmsd bond angle () 1.87 1.50 1.40 1.42
Number of atoms/ions
Protein 1,253 1,991 6,025 5,962
Peptide 0 0 286 255
Water 30 232 390 96
Platinum 7 0 0 0
Zinc 0 2 0 0
Sodium 0 0 4 0
Average B factor (Å2)
Protein 64.3 30.3 42.2 67.3
Peptide NA NA 60.7 76.2
Water 59.5 38.3 46.6 56.2
Platinum 216.9 NA NA NA
Zinc NA 23.7 NA NA
Sodium NA NA 56.6 NA
Ramachandran plot
Favoured 93.6 96.8 97.2 95.7
Allowed 5.7 3.2 2.7 3.9
Disallowed 0.7 0 0.1 0.4
APIM, AlkB homologue 2 PCNA Interacting Motif; HNH, His-Asn-His; NA, not applicable; PCNA, Proliferating Cell Nuclear Antigen; PIP, PCNA-Interacting Protein; Rmsd, root mean square deviation.
a Data for the highest resolution shell are given in parentheses.
*Rsym¼S|/-o/4|/S/, where / is measured density for reﬂections with indices hkl.
wRcryst¼S||Fobs|–|Fcalc||/S|Fobs|.
zRfree has the same formula as Rcryst, except that calculation was made with the structure factors from the test set.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms15847
4 NATURE COMMUNICATIONS | 8:15847 | DOI: 10.1038/ncomms15847 | www.nature.com/naturecommunications
α1
α2
α3
α4
α5
α6
β1
α7
β2
α8
c
H1021A H1045A
H.sapiens
M.musculus
D.rerio
A.thaliana
P.patens
L.panamensis
T.brucei
A.bacterium
S.usitatus
T.roseus
Mycobacterium
C.jejuni
E.coli
N.exalbida
Selenomonas
D.radiodurans
T4 endo VII
ZRANB3-type HNH insert
ZRANB3
HNH
nuclease
ZRANB3-like
HNH proteins
K1046A
K984A
R987A
K988A K998A R1009A R1048A
α1 α2 α3 α4 α5 α6 β1 β2 α8α7
Nucleophilic attack
Mg2+ Mg2+
D1020A N1036A
H1015AZn2+ Zn2+
ZRANB3-specific
helical domain
ZRANB3-specific
helical domain
White: ZRANB3-HNH
Yellow: T4 endo VII (2QNC)
White: ZRANB3-HNH
Orange: Geobacter metallireducens
HNH nicking endonuclease (4H9D)
α1
α2
α3
α4α5
α6
β1
α7
β2
α8
α1
α2
α3
α4α5
α6
α7
β2
α8
a b
Chain Z rmsd lali nres %id Description
1EN7-B 5.2 3.2 75 157 15
4H9D-C 4.8 3.1 65 81 22
5AXW-A 4.7 4.6 68 1043 15
Recombination endonuclease VII
HNH endonuclease
CRISPR-associated endonuclease CAS9
d
e
ATP
ZR
AN
B3
 W
T
ZR
AN
B3
-Δ9
75
-10
13
ZR
AN
B3
-Δ9
72
-10
10
+– + –– +
SNNSYLRAKVFETEHGVCQLCNVNAQELFLRLRDAPKSQ-RKNLLYATWTSK-LPLEQLNE-MIRNPGEGHFWQVDHIKPVYGGGGQCSLDNLQTLCTVCHKERTARQAKERSQVRRQSLA
SNNSYLRAQVFATEHGVCQHCGVDAQELFLRMRDAPKSH-RKSLLNAAWTAK-LPLEQLNE-MLRNPGEGHFWQVDHIRPVYEGGGQCSLDNLQTLCTVCHKERTAQQAKERSQVRRLSLA
SSQAYMRARVLEAEQGMCQQCGLNAHQLYLQVRDAPLTH-RKDMLDNTWLAQ-LPLKQLNE-MIQSPAEGQFWQVDHIKPVYRGGGQCSLENLQTLCTVCHRMRTAQQVKDRSQMKRNQTA
TSSRYIR----QIEHGICTNCKLDCHQLVKRLRPLPLEK-RRTYINKAAPELFARKNLLET-LVNDPTEGNAWHADHIIPVYQGGGECRLENMRTLCVACHADVTAAQCAERKLIRSKARK
TSRRRIREELFDLEGGVCVKCGLDCHALVERIRPLPVEL-RQAYVMEKASQFTKHKRMLQK-LVKEPIEGNAWHADHIIAVADGGGECTLENFQTLCIACHAEVTADQRRHRAAESLKTKL
RSGGAMRRSVAGVDKGVCSHCHVDCETLCTSVAAVTGRRERVAAIGRLHPQLLQFPTFCER-IVSNPIPGNFWHADHVVPVACGGGEATLDNLQTLCVVCHALKTQEDMKQVRQQRVVLPV
RSSSAARRGVQEVDKGICSVCQVDCELLYSLAVAATSRSEREDILDRLHPQLRQHPVLFNR-IVEHPTPGSIWNADHILAVSQGGGSSDLDNLQTLCVACHADKTVSEARVGYKAVSEKVP
TQPGYVREKVYERDRGVCSGCGVDTLAASRQLRYSRGER-RKALL-LHWG-------------LRTRTRRSLWDADHIVPVAEGGGECDLDNIRTLCLRCHRAATLELRRRMRERQGIGTR
SNPGYLREQVFARDKGVCALCGVDTELLRKDKRKLDYKA-RKQFE-KDWG-------------L----RRHLWDADHILPVAAGGGECGLANMRTLCLMCHRARHRAP-------------
SQPAYLRDHVYKRDKGRCCGCGIDTMAALRALKRSRGAK-REELM-LHWG-------------FKTRMRKSLWDADHIVPVVEGGGECDLANIRTLCVRCHRTVTAALRERIRKAKVAAML
TVPYALQQACFQRDNYTCQRCGFVG-----------------------------------------RPNAAELNADHIIPRAEGG-TDDLDNLETKCVPCHKHKTAEEARRGRHRRSGKRR
VAWRKLRNA-FINKNPFCIRCGKFA-----------------------------------------------KIVDHIKPIKQGGKKLSEENLQSLCLACHNEKTKNELKG----------
K-WTVIRARILKRDKGLCQLCLRAG-----------------------------------------VVS-EAKTVDHIIPKAYGG-TDADSNLQSLCCPCHKAKTARERIR----------
SISQEVKAQVWQRDGGRCVECGDG----------------------------------------------HYLEFDHIIPLSRGG-ATSAANLQILCRACNRAKGARI-------------
--YDDAYANAKVEGGYQCAKCGKVF-----------------------------------------S-GRHGLEVDHIKPMNDGG-QSVLDNLQVLCKSCNASKGDKAEE-----------
----AEVKKAIRKRDRVCLCCG----------------------------------------------KRTQLQVDHIQSRYAGG-THDLDNLQLLCQVCNNLKGTREMNFRQHVSPLTSG
KLYKEEKQKFYDAQNGKCLICQRELN---------------------------------------PDVQANHLDHDHELNGPKAG-----KVRGLLCNLCNAAEGQMKHKFNRSGLKGQGV
Figure 1 | Crystal structure of the ZRANB3 HNH domain. (a) Crystal structure of the ZRANB3 HNH domain (residues 948–1,067). Secondary structure
elements are annotated (helices a1–a8 and b-strands b1–b2). A bound zinc ion is shown as an orange sphere, with its four coordinating cysteine residues
shown as sticks. The ZRANB3-speciﬁc helical domain is shown in blue. (b) Top scoring structural homologues of the ZRANB3 HNH domain identiﬁed by
DALI search17. (c) Sequence alignment of the HNH domains from eukaryotic ZRANB3 proteins, bacterial self-standing HNH nucleases and bacterial
ZRANB3-like proteins. Secondary structure elements are shown for human ZRANB3 HNH domain only. Targeted mutation sites are indicated by red (basic
residues) and blue (active site residues) arrows; residues involved in zinc ion coordination are indicated by yellow arrows; T4 endonuclease VII active site
residues are indicated by purple arrows. (d) Overlay of the ZRANB3 HNH (white) with the structures of T4 endonuclease VII (yellow) and Geobacter
metallireducens HNH nicking endonuclease (orange). Non-catalytic zinc ions are shown as orange spheres. (e) Nuclease assay with full-length ZRANB3 and
the two mutants containing deletions of the ZRANB3-speciﬁc helical domain (ZRANB3-D975–1013 and ZRANB3-D972–1010). DNA substrate (splayed
DNA duplex ﬂuorescently labelled at the 50 end) and the resulting product of the nucleolytic cleavage (ﬂuorescently labelled DNA duplex with 50 overhang)
are indicated in the picture. Shown are reactions in the presence and absence of ATP. Reactions were analysed by native polyacrylamide gel electrophoresis.
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expressed YFP-ZRANB3 wild-type and mutant proteins in U2OS
cells, and induced replication stress by exposing the cells to
ultraviolet light (UV) irradiation. Following a 6-h recovery, we
evaluated recruitment of ZRANB3 to stressed replication forks by
measuring colocalization of YFP-ZRANB3 proteins with
endogenous PCNA. UV induced an increase in the number of
cells that formed ZRANB3 foci, and for wild-type ZRANB3 the
proportion changed from B20% of cells in undamaged
conditions to 495% following Ultraviolet irradiation (Fig. 5e
and Supplementary Fig. 5). The number of cells containing
focally concentrated ZRANB3 also increased with the PIP* and
DAPIM mutants following Ultraviolet irradiation, but not with
the PIP*-DAPIM double mutant, whose ability to form foci was
completely lost (Fig. 5e). Interestingly, the increase in the number
of cells containing ZRANB3 foci was more pronounced with the
PIP* mutant than with the DAPIM mutant, possibly suggesting a
speciﬁc role of the APIM motif in the replication stress response.
Comparative analysis of PCNA binding afﬁnities. We further
examined the association of PCNA and the peptides derived from
ZRANB3 by performing isothermal titration calorimetry (ITC)
(Supplementary Fig. 6). Analyses of the synthetic peptides
containing the PIP box or APIM motif sequences revealed
comparable afﬁnities of the two peptides for PCNA (KD values of
4.8 and 9.24 mM for the PIP box and the APIM motif,
respectively) (Supplementary Table 1). In agreement with pre-
vious studies, the association of the peptides with PCNA
ﬁtted a 1:1 stoichiometry, suggesting that the trimeric complex
can accommodate one peptide per monomer5,25–27. Furthermore,
the associations of ZRANB3 peptides were compared to the
interactions of peptides derived from other PCNA interacting
proteins (FEN1, p21 and Poli). The peptides were of equal length
and covered the homologous sequence within the PIP box region.
Our data showed that the afﬁnities of ZRANB3 peptides were
within the range of values detected for other PIP box peptides
(Supplementary Table 1).
Structures of the PCNA-PIP and PCNA-APIM complexes.
To gain molecular insight into the way the PIP box and the APIM
motif of ZRANB3 interact with PCNA, we crystallized and
determined the co-structures of PCNA with the ZRANB3 PIP
and APIM peptides (Table 1). Both the PCNA:ZRANB3(PIP)
and PCNA:ZRANB3(APIM) complexes show the typical
homo-trimeric PCNA structure, consisting of three PCNA
molecules in the asymmetric unit forming a trimeric ring28. Three
peptide molecules are visible in the structures, each of which
interacts with a different monomer in the PCNA trimer.
The PIP boxes found in PCNA interaction partners
can generally be categorized as either canonical (deﬁned by the
Q-x-x-[ILM]-x-x-F-[FY] consensus sequence) or non-canonical
(deviate from the canonical consensus). ZRANB3 has a canonical
PIP box (Fig. 4b) that binds to the PCNA ring in a manner
similar to other canonical PIP boxes (such as those found in p66
of Pold and FEN1; Figs 6a–f and 7i)5. Speciﬁcally, the conserved
glutamine (Gln519) in the PIP box peptide interacts with PCNA
by forming a hydrogen bond with the main-chain carbonyl of
Table 2 | Average rates of ATP hydrolysis determined by an NADH-coupled assay according to ref. 59.
Enzyme ATP hydrolysis rate (lmol l 1min 1) k (min 1)
WT ZRANB3 16.59±0.34 110.65±2.27
ZRANB3-speciﬁc HNH insert deletion mutants
ZRANB3-D975–1013 5.76±0.03 38.41±0.23
ZRANB3-D972–1010 4.83±0.90 32.24±6.00
Basic residues HNH mutants
K984A 20.93±2.01 139.56±13.45
R987A 6.34±0.40 42.31±2.70
K988A 18.83±1.94 125.55±12.95
K998A 15.12±0.48 100.85±3.22
R1009A 7.49±2.57 49.94±17.14
K1046A, R1048A 19.38±1.74 129.23±11.62
HNH active site mutants
H1015A 18.67±2.24 124.46±14.96
D1020A 12.94±0.67 86.32±4.49
H1021A 18.59±1.98 123.95±13.19
N1036A 14.05±2.46 93.71±16.43
H1045A 8.91±0.66 59.42±4.40
PCNA binding mutants
PIP* 20.71±0.86 138.10±5.76
DAPIM 20.24±0.70 134.95±5.22
PIP* DAPIM 20.40±4.40 136.02±29.39
Cancer associated mutants
T66A 0.45±0.03 3.02±0.21
R169H ND ND
G401D ND ND
R947Q 10.24±1.15 68.26±7.70
R947* 9.50±0.64 63.36±4.31
D1020Y 11.60±3.30 77.36±22.04
APIM, AlkB homologue 2 PCNA Interacting Motif; HNH, His-Asn-His; ND, not deﬁned; PCNA, Proliferating Cell Nuclear Antigen; PIP, PCNA-Interacting Protein.
ATP hydrolysis rate was calculated using the molar absorption coefﬁcient for NADH in water (6220 Lmol 1 cm 1) and the light path of 0.424 cm.
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Ala252, and by an additional contact with Ala208 via a
well-structured water molecule (Fig. 6e,f). Furthermore, Lys518
and His520 form main chain hydrogen bonds with Ile255 and
Pro253 of PCNA, respectively (Fig. 6e,f and Supplementary
Fig. 8a). On the other hand, residues Ile522-Phe526 form a 310
helix that orients the conserved hydrophobic residues
(also known as the ‘hydrophobic plug’1; Ile522, Phe525 and
Phe526 in the ZRANB3 PIP box) for docking into the
hydrophobic patch on the PCNA surface (Fig. 6d). While this
topology is conserved in other PIP box peptides, differences are
usually observed in the regions at the C-terminus of the PIP box
sequence. This region forms an antiparallel b-sheet with the
IDCL of PCNA in p21 (ref. 25) and FEN1 (ref. 6), but not in some
other proteins with canonical PIP boxes, such as the PIP box in
the p66 subunit of Pold5 or the PIP box in the intrinsically
disordered protein p15(PAF)29 (Fig. 7i). In the structure
presented here, the PIP box peptide is not long enough to form
extensive contacts with the IDCL.
Although the APIM motif has been characterized as a
PCNA-binding motif in a number of proteins3 (Fig. 7h), the
structural insight into its mode of interaction with PCNA is still
lacking. Our structure of PCNA:ZRANB3(APIM) shows that the
APIM motif occupies the same general binding site on the PCNA
surface as do canonical and non-canonical PIP boxes (Fig. 7a–c,i
and Supplementary Fig. 8c)30. Moreover, the basic topology of the
PIP box deﬁned by a 310 helix is conserved in the APIM motif
(Fig. 7d), despite the apparent differences in the amino-acid
sequence. The 310 helical conformation is stabilized by a network
of intramolecular hydrogen bonds; however, whereas in PIP
boxes this network does not seem to necessitate conservation of
the constituent residues, in the APIM motif it involves a
conserved basic residue (Arg1074 in ZRANB3; Fig. 7h), whose
side chain nitrogen interacts with the backbone carbonyl of
Asp1071. Moreover, Ile1072, Phe1075 and Leu1076 of the APIM
motif form a hydrophobic plug, analogously to the conserved
hydrophobic residues of the PIP box [ILM]-x-x-F-[FY] sequence
(Fig. 7d,i). As in the PIP box structure, the 310 helical
conﬁguration appropriately positions these residues into the
hydrophobic patch on the PCNA surface.
Despite these similarities, the APIM motif interacts with PCNA
in a speciﬁc way, which differs from previously characterized
interactions of PCNA-interacting peptides. The most notable
difference is the absence of a glutamine residue otherwise
conserved in canonical PIP boxes (Fig. 7i), whose side chain
forms both direct and water mediated hydrogen bonds with
PCNA25,29 (Fig. 6e). The APIM motif contains a glycine at the
analogous position (Gly1069), and is therefore unable to interact
with PCNA in the same manner; instead, it forms a main
chain–main chain hydrogen bond with Ile255 (Fig. 7f and
Supplementary Fig. 8b). In addition, the side chain hydroxyl
group of Ser1070 forms water mediated hydrogen bonds with
Ala252 and Ala208, while Ile1072 forms a main chain hydrogen
bond with His44 (Fig. 7e and Supplementary Fig. 8b). Differences
are also observed in the formation of hydrophobic interactions:
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Figure 2 | DNA binding surface. (a) Electrostatic surface potential (blue, positive; red, negative) of the ZRANB3 HNH domain. (b) Electrostatic surface
potential with indicated secondary structure elements. (c) Comparison of the T4 endonucleaseVII and ZRANB3 HNH domains. H2 helices in T4
endonucleaseVII stabilize separation between DNA strands in the Holliday junction (top). Helices H1 and H2 in T4 endonucleaseVII (orange; only one
subunit shown for clarity) align with helices a1 and a8 in the ZRANB3 HNH structure (yellow) (bottom). (d) Nuclease assay with the wild-type and mutant
ZRANB3 proteins in the presence and absence of ATP. Reactions were analysed by native polyacrylamide gel electrophoresis. Indicated are mobilities of the
ﬂuorescently labelled DNA substrate and product. (e) Quantiﬁcation of the ATPase and nuclease activities of the wild-type and mutant ZRANB3 proteins.
Shown are the averages of four ATPase and ﬁve nuclease reactions. s.d.’s are shown as error bars.
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Leu1076 of the tripartite hydrophobic plug in the APIM motif has
a smaller side chain than the corresponding phenylalanine of the
PIP box peptide, and does not intrude as deeply into the PCNA
binding pocket. This is not dissimilar to the non-canonical PIP
box interaction of Poli with PCNA, which also contains a leucine
residue at the corresponding position31.
The differences in the way the PIP box and the APIM motif of
ZRANB3 bind to PCNA extend beyond the hydrophobic pocket
on the PCNA surface. The C-terminal region of the APIM motif
interacts with the IDCL, providing an additional point of contact.
Speciﬁcally, the Val1077 of the APIM motif forms main-chain
hydrogen bonds with Gly127 of PCNA (Fig. 7g). Interestingly,
the corresponding region of PolZ interacts with PCNA in a
similar fashion and binds the same IDCL residue through
equivalently positioned Lys709 (ref. 31). This differs from the
extensive antiparallel b-sheets observed in the p21 and FEN1
PCNA complexes, which involve multiple intramolecular
contacts25,29.
Biological implications of ZRANB3 structural studies. Repli-
cation stress is one of the major factors that contributes to
genomic instability associated with the development of human
cancers32–34. Although the role of ZRANB3 in the replication
stress response has been evidenced by a number of studies9–11,35,
pathobiological importance of its function has not been
investigated. Interestingly, multiple ZRANB3 variants have been
identiﬁed in various human cancers, including endometrial
carcinomas, a malignancy characterized by marked genomic
instability36,37. Mapping the endometrial cancer associated
ZRANB3 variants onto the primary sequence of ZRANB3, we
noted that the majority localized to functionally relevant
domains, particularly the helicase core and the HNH
domain38,39 (Fig. 8a). Furthermore, bioinformatic analyses
(largely based on evolutionary conservation of the affected
amino acids and on structural properties) suggested high
probabilities of pathogenicity for majority of the ZRANB3
variants Supplementary Table 2.
Three of the variants are predicted to yield truncated products
(nonsense mutations E97*, R947* and a frameshift mutation
C1041Hfs*13, Supplementary Table 3). Among these, E97* is
expected to produce a functionally null allele, whereas R947* and
C1041Hfs*13 are both expected to yield endonuclease deﬁcient
ZRANB3. Intriguingly, we noted an elevated frequency of highly
conserved ZRANB3 residues among the mutations reported in
the study (T66A, K340T, G401D, F414C and D1020Y), among
which T66A and D1020Y are predicted to yield enzymatically
inactive ZRANB3. Speciﬁcally, Thr66 is a conserved residue of a
common nucleotide binding fold (known as the Walker A motif,
deﬁned by the G-X(4)-G-K-[TS] sequence), and its mutation is
expected to yield both ATPase and endonuclease deﬁcient
ZRANB3. On the other hand, Asp1020 was identiﬁed in this
study as an active site residue of the HNH endonuclease domain
(Fig. 3c), and its mutation to tyrosine could be predicted to ablate
the ZRANB3 endonuclease activity.
To investigate the functional signiﬁcance of cancer associated
ZRANB3 mutations, we puriﬁed relevant ZRANB3 mutant
proteins and tested their enzymatic activities. The majority of
the tested cancer associated mutations yielded nucleolytically
inactive ZRANB3 proteins (Fig. 8b,c). While in some mutants,
such as R947Q, R947* and D1020Y, this was not related to the
ATPase function (Fig. 8c, Table 2), in others the mutations caused
ablation of both ATPase and endonuclease activities. Some
mutations (K340T, F414C and C1041Hfs*13) resulted in
insoluble proteins.
Collectively, these data suggest a high frequency of
loss-of-function mutations in ZRANB3 that may impact on its
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Figure 3 | Characterisation of the ZRANB3 HNH active site. (a) Overlay of the T4 endonucleaseVII (yellow) and the ZRANB3 HNH (white) structures.
Electrostatic surface potential of the HNH domain shows an overlap of the electronegative patch (red) with the Mg2þ ion (purple) in the T4
endonucleaseVII active site. (b) Overlay of the T4 endonucleaseVII (yellow, labels in italics) and the ZRANB3 HNH (white) structures. Mg2þ ion in T4
endonuclease is shown as a purple sphere. His1021, Asp1020 and His1045 in the HNH structure overlap with the active site residues of T4
endonucleaseVII. (c) Nuclease assay with the wild-type and mutant ZRANB3 proteins in the presence and absence of ATP. Reactions were analysed by
native poly-acrylamide gel electrophoresis. Indicated are mobilities of the ﬂuorescently labelled DNA substrate and product. (d) Nuclease assay with non-
hydrolysable ATP homologues. Shown are controls with the wild-type ZRANB3 and the ATPase dead K65R mutant in the presence of ATP.
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role in the replication stress response, and consequently on
genomic stability.
Discussion
Strategies to resolve replication blocks are critical for our
understanding of basic molecular mechanisms that underlie the
molecular basis of tumourigenesis. We have previously identiﬁed
ZRANB3 as a structure-speciﬁc endonuclease that plays a role in
the replication stress response9. A particularly interesting aspect
of ZRANB3 function is that its nuclease activity strictly depends
on active ATP hydrolysis (Figs 1e and 3c,d). Such dependence is
unusual, but was previously observed in some bacterial nucleases
(RecB and AddAB)40,41, and in eukaryotic DNA2 (ref. 42).
Interestingly, the ATPase and nuclease active sites of ZRANB3
reside in two discrete domains within the ZRANB3 structure: the
helicase core domain and the HNH domain, respectively.
Although many structure-speciﬁc nucleases have been studied
in detail, ZRANB3 is relatively underexplored and the molecular
basis of its nuclease activity lacked structural insight. Our detailed
analyses highlighted similarities between ZRANB3 and two
structure-speciﬁc endonucleases: T4 endonuclease VII (structu-
rally related to ZRANB3 HNH domain) and FEN1 (structurally
unrelated, but regulated by similar PCNA-dependent mechan-
isms). We further deﬁned PCNA as a key regulator of ZRANB3
function, which recruits ZRANB3 to the sites of stalled DNA
replication and stimulates its endonuclease activity. We also
examined the way ZRANB3 interacts with PCNA by solving
structures of PCNA:ZRANB3(PIP) and PCNA:ZRANB3(APIM)
complexes. We found that, despite dissimilarities between the PIP
box and the APIM motif consensus sequences, both motifs
occupy the same binding site on the PCNA surface30 and share
the basic topology with a characteristic 310 helix. However, our
data also point to the differences between the two motifs, and
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reveal speciﬁc interaction networks by which they form stable
PCNA complexes.
Collectively, these results highlight the importance of speciﬁc
molecular interactions in ﬁne-tuning PCNA-binding afﬁnities.
This has important implications in the biological context, where
PCNA coordinates a broad spectrum of activities involved in the
genome replication and maintenance of its integrity1. To achieve
this, PCNA must interact with a wide range of protein factors,
either simultaneously or sequentially. PCNA therefore acts as a
platform for the formation of speciﬁc molecular complexes,
which are selected based on their relative PCNA-binding
afﬁnities43. The highest afﬁnity reported to date is that of the
p21 PIP box5, which enables it to displace replicative polymerases
from the common binding site on the PCNA surface, and
consequently to act as a cell cycle inhibitor. On the other hand,
moderate PCNA-binding afﬁnities seem to be well suited to
support the formation of complexes of a more transient nature,
such as those with translesion DNA polymerases or ZRANB3.
Interestingly, increasing the PCNA-binding afﬁnity of several
PCNA partners in yeast resulted in severe in vivo phenotypic
defects44, suggesting that the fragility of PCNA complexes plays
an important role in conferring the appropriate biological activity.
Additional levels of complexity are achieved by the trimeric
structure of the PCNA ring, and the fact that many PCNA
binding proteins contain multiple PCNA binding motifs. The
simultaneous occupation of PCNA protomers by separate PCNA
binding motifs might therefore be a possibility for proteins like
ZRANB3. This might not only be relevant for the stability of the
complex, but also for its orientation and positioning on the DNA
template. Finally, formation of speciﬁc protein:PCNA complexes
is additionally modulated by post-translational modiﬁcations.
Previous work demonstrated that polyubiquitinated PCNA
recruits ZRANB3 to stalled replication forks, which is facilitated
by the speciﬁc polyubiquitin binding motif NZF9,10, conserved
among ZRANB3 proteins. Importantly, polyubiquitination of
PCNA is known to regulate an error free pathway of cellular
response to replication stress. This pathway, also known as
template switching, uses the newly synthesized sister chromatid
as a temporary template for DNA synthesis across the lesion45,
and is conserved from yeast to humans46. The interactions
through the NZF motif might therefore provide an additional
level of regulation of the ZRANB3:PCNA complex and its activity
at the replication fork.
Finally, our structural and biochemical ﬁndings allowed us to
interpret the functional signiﬁcance of cancer associated variants
in ZRANB3. We analysed ZRANB3 mutations associated with
endometrial carcinomas and noted a high incidence of mutations
predicted to yield functionally deﬁcient proteins (Supplementary
Table 2 and Fig. 8). Strikingly, the identiﬁed cancer-related
mutations included the missense mutations targeting both of the
ZRANB3 catalytic active sites: the ATPase active site contained
within the helicase core, and the endonuclease active site in the
HNH domain. Both of these mutations yielded nucleolytically
inactive proteins (Fig. 8b,c), highlighting the biological
signiﬁcance of the ZRANB3 endonuclease function in this
context.
Collectively, these results provide important insights into the
structure and regulation of ZRANB3, and its association with
PCNA. They also improve our understanding of the principal
mechanisms employed by PCNA to interact with its protein
partners. This seems particularly relevant, as emerging evidence
suggests that targeting the PCNA binding surface might be a
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promising strategy in cancer therapeutics47,48. Detailed
understanding of the dynamic nature of PCNA interactions
might therefore open new possibilities for rational drug design.
Methods
Plasmids. Human ZRANB3 was cloned into a pFASTBac-His6-TEV vector for
puriﬁcation of the full-length ZRANB3 with an N-terminal His tag from insect
cells. Point mutations and internal deletions in ZRANB3 gene were introduced
using the QuickChange II site-directed mutagenesis kit (Stratagene). ZRANB3
HNH domain constructs (amino acids 948–1,067 and amino acids 871–1,079) were
subcloned into pNH-TrxT vector for bacterial expression of proteins with
N-terminal His and Trx tags (kindly provided by Opher Gileadi, SGC Oxford;49).
PCNA was cloned into NcoI and XhoI sites of pET28a vector for the expression of
the untagged protein, and into NdeI and XhoI sites for the expression of the
protein with N-terminal His-tag. FEN1 was cloned into pET28a for the expression
of the protein with C-terminal His-tag. Oligonulceotide sequences are listed in
Supplementary Methods.
Proteins. Full-length ZRANB3 and its mutants were expressed in High5 insect
cells (Fisher Scientiﬁc). Expression of the ZRANB3 variants was initiated by
infecting the cells (100ml at 2 106 cells per ml 1) with P1 virus at MOI
(multiplicity of infection) B1. The cells were collected 48 h post infection and
resuspended in lysis buffer (25mM Tris-HCl at pH 8, 0.3M NaCl, 10% glycerol,
1%Triton-X, protein inhibitor cocktail, 5mM imidazole, 250U benzonase ml 1 of
lysate). The cleared lysate was passed through Ni-NTA beads, equilibrated with
50mM Tris-Cl pH 8, 500mM NaCl, 10mM imidazole, 1mM DTT. ZRANB3 was
eluted with the same buffer containing 500mM imidazole. To remove His-tag, the
proteins were incubated with TEV protease overnight, reapplied to Ni-NTA beads,
and then puriﬁed over a Superdex 200 10/300 column in 50mM Tris-HCl pH 8,
500mM NaCl and 1mM DTT. Glycerol (ﬁnal concentration 10%) was added to
puriﬁed proteins before they were snap-frozen in liquid nitrogen and stored at
 80 C.
The ZRANB3 HNH domain (amino acids 948–1,067) used in protein
crystallization was expressed from the pNH-TrxT vector by an overnight
induction with 0.1mM IPTG at 18 C. Cells were lysed in lysis buffer (50mM
Tris-HCl pH 8, 500mM NaCl, 10mM imidazole, 4mM b-mercaptoethanol,
2mgml 1 lysozyme, protease inhibitor cocktail (Roche) and 25 unitsml 1 of
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benzonase (Sigma-Aldrich)) by applying three passages through a French-press at
15,000 Psi and insoluble material was pelleted for 90min at 35,000 g. The cell
extract was applied to Ni-NTA beads (Qiagen) equilibrated to lysis buffer, and the
protein was eluted by increasing the concentration of imidazole to 500mM. The
protein was then incubated with TEV protease overnight, which removed His and
Trx tags from the HNH domain. Cleaved protein was subsequently reapplied to
Ni-NTA beads (to remove tags and TEV protease), and then puriﬁed over a
Superdex S-200 (16/600) column in 20mM Tris-HCl pH 7.5, 100mM NaCl and
1mM DTT. Homogenous HNH domain was concentrated to a ﬁnal concentration
of B30mgml 1 and used to set-up crystallization trials.
ZRANB3 HNH domain (amino acids 871–1,079) used for the electrophoretic
mobility-shift assay was expressed from the pNH-TrxT vector, by a 4 h induction
with 0.4mM IPTG at 30 C. The wild-type and mutant proteins were puriﬁed over
Ni-NTA beads (Qiagen) analogously to the ZRANB3 HNH domain (amino acids
948–1,067). To remove imidazole, fractions containing the HNH domain were
passed through a NAP-10 desalting column (GE healthcare), equilibrated with
storage buffer (50mM Tris-HCl pH 8.0, 500mM NaCl, 1mM DTT). Before
freezing, glycerol was added (ﬁnal concentration 10%), and the samples were
snap-frozen in liquid nitrogen and kept in small aliquots at  80 C.
Untagged PCNA for crystallization was expressed in Escherichia coli from
pET28a vector during a 4 h induction with 0.4mM IPTG at 30 C. Cells were lysed
in lysis buffer (50mM Tris-HCl pH 8, 150mM NaCl, 1mM DTT, 2mgml 1
lysozyme, protease inhibitor cocktail (Roche) and 25 unitsml 1 of benzonase
(Sigma-Aldrich)) by applying tree passages through a French-press at 15,000 Psi
and insoluble material was pelleted for 90min at 35,000 g. The cleared supernatant
was puriﬁed over a 10ml Q-sepharose column equilibrated to Buffer A (50mM
Tris-HCl pH 8, 150mM NaCl and 1mM DDT). Proteins were eluted with 50mM
Tris-HCl pH 7.5, 1mM DDT and a gradient of 150–550mM NaCl. Fractions
containing PCNA were pooled and loaded onto a 1ml S-sepharose column
equilibrated to Buffer A. The ﬂow-through (containing PCNA) was passed
through a 5ml Hi-Trap Heparin column equilibrated with Buffer A. Finally, the
ﬂow-through (containing PCNA) was loaded onto a 5ml Q-sepharose column
equilibrated with Buffer A. PCNA was eluted in Buffer A with a gradient of
50–500mM NaCl. Fractions containing PCNA were pooled, concentrated and
loaded onto a Superdex S-200 (16/600) column equilibrated with storage buffer
(20mM Tris-HCl pH 8, 100mM NaCl, 1mM DTT). Homogenous PCNA was
concentrated to a ﬁnal concentration of B20mgml 1 and used to set-up
crystallization trials.
His-tagged PCNA was expressed in E. coli from pET28a vector under the same
conditions as the untagged PCNA. Cells were lysed in lysis buffer (50mM
Na-Phosphate pH 8, 500mM NaCl, 1mM b-mercaptoethanol, 10mM imidazole,
2mgml 1 lysozyme, protease inhibitor cocktail (Roche) and 25 units ml 1 of
benzonase (Sigma-Aldrich)).The protein was applied to Ni-NTA beads (Qiagen)
equilibrated to lysis buffer, and eluted by increasing the concentration of imidazole
to 500mM. The protein was then applied to a 5ml Q-sepharose column
equilibrated to the PBS buffer containing 1mM b-mercaptoethanol and eluted in
the same buffer with 150–500mM NaCl gradient. Fractions containing PCNA were
puriﬁed over a Superdex S-200 (16/600) column equilibrated to the PBS buffer
containing 1mM b-mercaptoethanol. Before ITC measurements, PCNA was
concentrated to B600 mM and extensively dialysed against the PBS buffer
containing 1mM b-mercaptoethanol, along with the ligand peptides.
Crystallization and data collection and structure solution. Crystallization trials
were performed with commercial screens using the sitting-drop vapour-diffusion
method. Crystallization drops were set-up with the aid of a Mosquito Crystal robot
(TTP Labtech) using 200 nl of protein solution plus 200 nl of reservoir solution in
MRC two-well crystallization microplates (SWISSCI ‘MRC’) equilibrated against
75 ml of reservoir solution.
Crystals of the ZRANB3 HNH domain (amino acids 948–1,067) used for
anomalous phasing grew in 20% PEG 6,000, 100mM BICINE pH 9.0 at 4 C and
were soaked in crystallization solution with 5mM K2PtCl4 for 10min to obtain
anomalous X-ray data for SAD experiments. Co-crystallization trials of HNH with
dsDNA (50-GCGATCGC-30) produced crystals that grew in 20% PEG 10,000 and
100mM HEPES pH 7.5 at 4 C. Electron density for the dsDNA ligand could not
be observed in the structure, even though crystals failed to form under identical
crystallization conditions in the absence of the dsDNA ligand.
Peptides 511FTHFEKEKQHDIRSFFVPQPKK532 and 515EKEKQHDIRSFFVPQ529
were used for crystallization of PCNA:PIP complex. Co-crystals were obtained with
both peptides, but peptide 511FTHFEKEKQHDIRSFFVPQPKK532 was more
disordered at the C-terminus and residues beyond Phe526 were not visible. Co-crystals
of PCNA and the PIP peptide (515EKEKQHDIRSFFVPQ529; 1:10 molar ratio) grew in
100mM NaCl, 8% DMSO and 31% pentaerythritol propoxylate at 20 C. Co-crystals
of PCNA and the APIM peptide (1066SKHGSDITRFLVKK1079; 1:15 molar ratio) grew
in 100mM lithium sulfate, 30% polyvinylpyrrolidone and 100mM HEPES pH 7.0 at
20 C. All crystals were cryoprotected by a 2–5 s soak in crystallization solution with
20% glycerol, before being vitriﬁed by submersion in liquid nitrogen.
X-ray data were collected at beamlines I03, I04 and I04-1 at the Diamond Light
Source (Rutherford Appleton Laboratory, Harwell, UK) and data collection
statistics for HNH, PCNAþ PIP and PCNAþAPIM are shown in Table 1.
Anomalous data of ZRANB3 HNH were collected at the Pt L-III absorption
edge to 2.50Å resolution. The structure was solved by SAD phasing, which located
seven platinum ions and was followed by density modiﬁcation and automated
model-building. The resulting model was subsequently used to solve the 1.96Å
native data from a co-crystallization trial with dsDNA by molecular replacement.
The PCNAþ PIP and PCNAþAPIM structures were solved by molecular
replacement with a native human PCNA structure (PDB code: 1VYM) as the
molecular replacement model.
X-ray data were processed using Xia2 (ref. 50). SAD phasing, initial density
modiﬁcation and automated model-building were carried out with AUTOSOL51.
PHASER52 was used for phasing by molecular replacement. Subsequent density
modiﬁcation automated model building were implemented with PARROT53 and
BUCCANEER54, respectively. Model building was carried out with COOT55 and
real space reﬁnement with REFMAC5 (ref. 56), coupled with automatically
generated local non-crystallographic symmetry restraints and TLS reﬁnement.
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Figure 8 | Cancer associated ZRANB3 mutations. (a) ZRANB3 mutations associated with endometrial carcinomas. Shown are positions of the mutations
targeting conserved residues. Truncating mutations are indicated as black dots. (b) Nuclease assay with the wild-type and cancer associated mutant
ZRANB3 proteins, in the presence and absence of ATP. Reactions were analysed by native polyacrylamide gel electrophoresis. Indicated are mobilities of
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Figures were prepared with PyMOL (The PyMOL Molecular Graphics System,
Version 1.8 Schro¨dinger, LLC) and UCSF Chimera57, using DSSP58 for secondary
assignment.
Nuclease assays. Oligonucleotides used in the nuclease assays (50-AGGTCTCGA
CTAACTCTAGTCGTTGTTCCACCCGTCCAC-CCGACGCCACCTCCTG-30
and Cy3 50-end-labelled 50-CGTCCTCCACCGCAGCCCACCTGCCCACCTAAC
TT-TAAATCCGACCGTGCCAGC-30) were incubated in 10mM Tris-HCl pH 7.5,
50mM NaCl for 3min at 94 C, after which the reactions were allowed to gradually
cool down.
The nuclease assays with ZRANB3 was performed essentially as described in
ref. 9. Brieﬂy, reaction mixtures containing the indicated nuclease (200 nM) and
ﬂuorescently labelled DNA substrate (10 nM) in 10 ml of reaction buffer (50mM
Tris-HCl; 50mM NaCl; 5mM MgCl2; 2mM ATP (Sigma); pH 7.5) were incubated
at 30 C for 60min. The reactions were stopped by incubation with 0.1% SDS and
4mgml 1 of proteinase K at 30 C for 45min. The reactions were then mixed with
sucrose (10% ﬁnal concentration) and resolved in a 10% polyacrylamide gel in
0.5TBE buffer (45mM Tris-borate, 1mM EDTA; pH 7.5). The ﬂuorescent DNA
species were visualized and quantiﬁed using Pharos Mx imager and Quantity one
software (BioRad).
ATPase assays. The ATPase activity of ZRANB3 was examined by two methods:
one, based on resolution of radioactive 32Pi product by thin layer chromatography
(TLC), and the other, measuring time-dependent consumption of ATP using an
NADH-coupled assay.
The TLC-based ATPase assay was performed essentially as described9. Brieﬂy,
the reactions were performed in presence of 10 mM ATP, 0.1 mCi of [g-32P]ATP
(3,000 Cimmol 1) (Perkin Elmer), 50mM Tris-HCl pH 7.5, 5mM MgCl2,
200 nM ﬂap DNA and 162 nM of ZRANB3 proteins in a 5-ml reaction volume.
Where indicated, DNA was added to the reaction. After a 30min incubation at
30 C, the reactions were stopped by the addition of 50mM EDTA. In a set of
control experiments, 5.27 mM RecA recombinase (in the presence or absence of
virion FX-174 DNA; 115 nM) was used according to the manufacturer’s
instructions. Reaction products were spotted onto a polyethyleneimine (PEI)-
cellulose plate (Macherey-Nagel, Polygram CEL 300 PEI UV254 1) and developed
in 0.15M LiCl and 0.15M formic acid. Dried plates were exposed onto an X-ray
ﬁlm.
The NADH-coupled ATPase assay is based on a reaction in which the
regeneration of hydrolysed ATP is coupled to the oxidation of NADH59. It was
used as described59, with minor modiﬁcations. ZRANB3 (150 nM) was added to a
150ml reaction containing 25mM Tris-Cl pH 7.5, 13mM MgCl2, 1.8mM DTT,
100mgml 1 BSA, 3mM phosphoenolpyruvate, 36Uml 1 pyruvate kinase,
20Uml 1 lactate dehydrogenase, 0.5 mM ﬂap DNA, and 5mM ATP, with 750 mM
NADH added immediately before ZRANB3. Reactions were mixed for 1min on a
shaker at 23 C and analysed by measuring A340 nm at 20 s intervals during 60min,
on a Spectramax 250 microplate spectrophotometer at 24 C. Linear titration of
freshly prepared NADH was performed to obtain a standard curve for units of
absorbancemM 1 NADH. ATPase rates were calculated from data collected
between time points where product formation was linear with respect to time.
Isothermal titration calorimetry. PCNA and peptides used in our study were
extensively dialysed against PBS containing 1mM b-mercaptoethanol. The
concentration of the peptides was determined at A205 nm, using a molar
absorptivity calculated speciﬁcally from the amino-acid sequence60.
The measurements were performed at 25 C using MicroCal PEAQ-ITC
(Malvern). In a standard experiment, the reaction chamber was ﬁlled with a 15 mM
solution of PCNA. The peptides were injected stepwise (20 injections of 2 ml).
Concentrations of the peptides in the syringe were as follows: p21 (147 mM); Poli
(398 mM); FEN1 (410 mM); ZRANB3 PIP (311 mM); ZRANB3 APIM (327 mM). The
obtained results were processed and analysed using MicroCal PEAQ-ITC Analysis
Software. The free Gibbs energy (DG), Enthalpy change (DH) and stoichiometry
(N) were determined by Levenberg–Marquardt curve-ﬁtting method employing
single set of independent binding sites model. Association constant (KA) was
determined using the following equation DG¼ RTln (KA). Association constant
(KD) is inverse function of the dissociation constant KA. Finally, the entropy
difference (TDS) was obtained from the following equation: DG¼DH–TDS.
PCNA pull-downs. Biotinylated PIP-box and APIM-motif peptides were synthe-
sized by Genscript. Magnetic streptavidin beads (Life Technologies) were used to
immobilize the peptides, which were then washed with 50mM Tris-HCl pH 8,
150mM NaCl, 1mM DTT and 0.2% Triton-X. The beads were then incubated with
His-tagged recombinant PCNA for 1 h at 4 C. The beads were subsequently
washed with the same buffer to remove unbound PCNA, after which they were
boiled in the SDS-PAGE loading buffer, and analysed by anti-PCNA Western
blotting (ab18197, 1:1,000 dilution).
Electrophoretic mobility-shift assay. DNA substrate was prepared by mixing a
1.5-fold excess of unlabelled oligonucleotide (50-CGACTTCCGGTAGCACGTA
GCAGCGGCTCGCCACGAACTGCACTCTAGGC-30) over the 50 32P-labelled
oligonucleotide (50-CCTCGATCCTACCAACCAGATGACGCGCTGCTACGT
GCTACCGGAAGTCG-30). The oligonucleotides were annealed in 10mM
Tris-HCl pH 7.5, 50mM NaCl by slow cooling of reactions from 94 C. Puriﬁed
Trx-tagged wild-type and mutant HNH domains (amino acids 871–1,079) were
incubated with radioactively labelled substrate (1 nM) at 4 C in 15ml of reaction
buffer (50mM Tris-HCl pH 7.5, 5% glycerol, 4mM EDTA, 1mM DTT and
0.1mgml 1 BSA) for 30min. After the incubation, the reaction mixtures
were resolved in a 5% native polyacrylamide gels in 0.5TBE buffer (45mM
Tris-borate, 1mM EDTA; pH 7.5) at 4 C. Resolved gels were dried and visualized
by autoradiography.
Immunoﬂuorescence. U2OS cells (ATCC) were seeded onto glass coverslips and
transfected with the YFP constructs using Lipofectamine 2000 (Life Technologies).
The following day, the cells were ﬁrst washed with PBS, and then incubated in
pre-extraction buffer (10mM PIPES, 300mM sucrose, 3mM MgCl2, 20mM NaCl,
0.5% Triton-X) for 5min at  20 C. They were then ﬁxed in 4% paraformalde-
hyde for 15min, permeabilized with 0.5% Triton-X for 5min, washed in PBS and
further incubated in 2% BSA for 30min. The cells were then stained with the rabbit
PCNA antibody (Abcam, ab18197, 1:300 dilution), washed in PBS, and incubated
with the anti-rabbit secondary antibody coupled to Alexa Fluor 594 (Life
Technologies). The coverslips were mounted in ProLong Gold anti-fade reagent
with DAPI (Life Technologies) and analysed by confocal microscopy.
For studies involving YFP-NLS-PIP and YFP-NLS-APIM constructs, the
following sequences were introduced to the C-terminus of YFP:
GFMRAPKKKRKVGGFTHFEKEKQHDIRSFFVPQPKK (for YFP-NLS-PIP),
GFMRAPKKKRKVGGFTHFEKEKAHDIRSAAVPQPKK (for YFP-NLS-PIP*),
GFMRAPKKKRKVGGQVRRQSLASKHGSDITRFLVKK (for YFP-NLS-APIM)
and GFMRAPKKKRKVGGQVRRQSLASKHGSDITRALVKK (for YFP-NLS-
APIM*).
For the recruitment of ZRANB3 to stalled replication forks, U2OS cells were
seeded onto glass coverslips and transfected with YFP-ZRANB3 constructs. The
following day they were treated with UV (40 Jm 2), and allowed to recover for 6 h.
This was followed by pre-extraction and staining with the PCNA antibody, exactly
as described above. Finally, the samples were analysed by confocal microscopy. For
each experiment, more than 100 cells were counted, and the results from three
independent transfections were pooled for statistical analyses.
Live-cell imaging by laser microirradiation. U2OS cells were grown in
glass-bottomed dishes and transfected with the appropriate YFP constructs using
Lipofectamine 2000 (Life Technologies). They were sensitized with 10 mM BrdU for
16 h at 37 C. Laser microirradiation was carried out on an Olympus confocal
microscope equipped with an environmental chamber. Cells showing moderate
levels of expression were systematically chosen using identical 488-nm laser
settings. DNA damage was induced by 405 nm laser and recruitment of the
proteins was monitored by live cell imaging.
Bioinformatic analyses of pathogenicity. Pathogenicity of ZRANB3 variants was
evaluated by PolyPhen-2 (ref. 61), SIFT62, Mutation Assessor63 and Mutation
Taster2 (ref. 64).
Data availability. Coordinates and structure factors were deposited in the Protein
Data Bank with accession codes: 5MKW (Crystal structure of the human ZRANB3
HNH domain), 5MLO (Crystal structure of human PCNA in complex with the
ZRANB3 PIP box peptide) and 5MLW (Crystal structure of human PCNA in
complex with the ZRANB3 APIM motif peptide). All other data are available from
the corresponding author on reasonable request.
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